Medicilon Earns OECD GLP Certification from Hungary, Strengthening Global Compliance Network
Shanghai, China – October 9, 2025 – Medicilon is proud to announce that it has officially obtained certification of compliance with OECD Good Laboratory Practice (GLP) standards from Hungary, a member country of the Organization for Economic Co-operation and Development (OECD). This achievement marks another important milestone in Medicilon’s continuous pursuit of international quality excellence, […]
Medicilon Empowers Strategic Partner SAPU to Obtain Clinical Trial Approval for Sapu003 in Australia
Recently, Sapu003, an innovative drug developed by SAPU Bioscience, has officially obtained clinical trial approval in Australia. This is the first successfully approved IND since Medicilon and SAPU entered into a strategic agreement for 20 IND projects in February this year. The quality and speed of this approval serve as a strong testament to the […]
Medicilon Receives International Accreditation Again! Successfully Obtains OECD GLP Certificate
Recently, Medicilon has officially obtained the Good Laboratory Practice (GLP) certificate issued by Mexico, a member country of the Organization for Economic Co-operation and Development (OECD). Medicilon also has passed the GLP on-site inspections conducted by Hungary, another member country of the OECD. Following the recent FDA and PMDA GLP audit , this success further […]
